Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
The Cancer-Killing Nanorobots are Coming
Posted on April 26th, 2019 by Elia Lima-Walton, MD in Pharma R&D
In recent years, robotics, AI, and Machine Intelligence have been at the forefront of the symbiotic need for humans and our own AI technology to work together. Last year, ground breaking research by molecular chemists at Arizona State University has taken cancer research and treatment to a new level. They are in the process of developing an “origami-inspired” system that can identify the tumor, attack, and deploy a mechanism to suffocate the tumor. Innovation is everywhere in this field, and this one is truly amazing.
(more…)On World Malaria Day, Assessing Progress in the Fight Against a Persistent Disease
Posted on April 25th, 2019 by Nicki Catchpole in Pharma R&D
Today marks the WHO’s worldwide recognition of those affected by malaria and the widespread global effort to develop a cure. The Elsevier Professional Services team exemplifies this effort with the creation of a database covering interactions and functions of P. faciparum proteins. This is the deadliest of the Plasmodium species that cause malaria in human beings.
(more…)Robots, Reactions & Automated Labs
Posted on April 18th, 2019 by Elia Lima-Walton, MD in Pharma R&D
Elseiver’s Elia Lima-Watson, MD explores the phenomenon of automation int he lab beyond just rote tasks. Fascinating developments in this field and others continue to accelerate the discovery process at a dizzying rate.
(more…)Integrating Chemistry Data Sources Provides Big Benefits
Posted on April 17th, 2019 by Abhinav Kumar in Pharma R&D
Unification across platforms is providing multiple benefits to organizations who pull together massive amounts of data across multiple platforms. Technology is evolving to eliminate data redundancy and silos as evidenced by the collaboration between Elsevier and Lundbeck.
(more…)
